Johnson & Johnson

Studies involving COVID-19 vaccine candidates in monkeys show promise of an effective vaccine, but it will take large-scale human trials to know for sure if they work.

The company says it didn't intend to suggest that fairness or white was "better than your own unique skin tone." Other major companies have announced changes to advertising tactics seen as racist.

The company said demand has declined "fueled by misinformation around the safety of the product and a constant barrage of litigation advertising." Lawsuits allege the powder causes cancer.

The Department of Health and Human Services outlines support for Moderna and Johnson & Johnson, as the companies work to develop coronavirus vaccines. Beefing up manufacturing capacity is a priority.

The new number from Judge Thad Balkman comes nearly three months after he ordered the drugmaker to pay $572 million for its role in the opioid crisis. Both sides had questioned that sum.

The largest-ever federal action related to the U.S. opioid crisis is on the cusp of its first trial next week — and it's complicated. So here's a brief(ish) explainer breaking it all down.

The agreement removes the drugmaker from the list of defendants in an upcoming federal opioid trial and follows an August settlement in Oklahoma in which it agreed to pay $572 million.

The $572 million judgment against Johnson & Johnson will cover one year of addiction treatment and prevention the judge says. But health economists predict it will take decades to abate the problem.

The first civil trial against an opioid manufacturer, Johnson & Johnson, has ended in Oklahoma. The verdict could affect lawsuits filed by other local and state governments coping with addiction.

The health care giant faces multiple lawsuits, including one over opioids. A reputation for corporate responsibility, dating back to the Tylenol scandal, offers some protection but no guarantee.

Infants' Tylenol is the same strength as Children's Tylenol. Turns out, the price difference has to do with packaging and safety features.

The woman said she used J&J talc-based products in the 1960s and '70s and later developed mesothelioma. The pharmaceutical company says its product is safe and plans to appeal.